Search results for "Cutaneous"

showing 10 items of 1022 documents

Recurrent cerebral ischaemia in a pregnant woman with patent foramen ovale II° and thrombophilia.

2014

SummaryThis case report concerns a pregnant multipara (age: 27 years) in the 16th gestational week. She developed a sudden onset of paraesthesia in her left lower arm although injecting dalteparin 5000 IU once daily subcutaneously (s. c.) due to a heterozygous factor V Leiden mutation and a prior miscarriage in the first pregnancy and preeclampsia in her third pregnancy. After the miscarriage she delivered two healthy children under prophylactic anticoagulation with low molecular weight heparin (LMWH). Now via magnetic resonance imaging (MRI) she was diagnosed as having multiple cerebral ischaemic lesions. Further workup revealed the presence of a patent foramen ovale (PFO) II° but no venou…

AdultDalteparinmedicine.medical_specialtymedicine.drug_classInjections SubcutaneousPregnancy Complications CardiovascularLow molecular weight heparinForamen Ovale PatentThrombophiliaPreeclampsiaMiscarriageBrain IschemiaPregnancyRecurrencemedicineHumansThrombophiliaPregnancybusiness.industryPregnancy Complications HematologicAnticoagulantsHematologymedicine.diseaseSurgeryVenous thrombosisTreatment OutcomeAnesthesiaPatent foramen ovaleGestationFemalebusinessHamostaseologie
researchProduct

High CCL27 immunoreactivity in ‘supratumoral’ epidermis correlates with better prognosis in patients with cutaneous malignant melanoma

2016

AimsIt has been proposed that the expression of chemokines and chemokine receptors by melanoma cells may have a role in tumour immune escape. Chemokine CCL27 is reported to be expressed specifically on the epidermal keratinocytes. The implication of CCL27 in cutaneous melanomas is currently unresolved. It has been suggested that CCL27 expression in melanomas can induce antitumoral immunity, and that CCL27 may suppress tumour growth probably due to the local lymphocyte recruitment.MethodsWe studied CCL27 chemokine expression in three different concentric epidermal areas covering the primary cutaneous melanoma in patients with a long clinical follow-up. Our study included 91 cases of primary …

AdultKeratinocytesMale0301 basic medicinePathologymedicine.medical_specialtyChemokineSkin NeoplasmsLymphocyteBiologyDisease-Free SurvivalPathology and Forensic MedicineYoung Adult03 medical and health sciencesChemokine receptor0302 clinical medicinemedicineHumansMelanomaAgedAged 80 and overEpidermis (botany)Chemokine CCL27MelanomaGeneral MedicineMiddle AgedPrognosismedicine.diseaseImmunohistochemistrySurvival Rate030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisCutaneous melanomabiology.proteinImmunohistochemistryFemaleCCL27EpidermisJournal of Clinical Pathology
researchProduct

Measurement of body composition in cancer patients using CT planning scan at the third lumbar vertebra

2019

Objective: the main objective was to assess body composition in terms of skeletal muscle index (SMI), myosteatosis, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intermuscular adipose tissue (IMAT) as an adjunct of information provided by radiotherapy CT planning scan. Material and methods: a sample of 49 patients with lung and digestive cancers underwent a CT scan for radiotherapy treatment, which included measurements at the L3 region. Images were analyzed with a radiotherapy contouring software, using different Hounsfield Unit (HU) settings. Cross-sectional areas (cm2) were automatically computed by summing tissue pixels and multiplying by pixel surface area. Low …

AdultMale0301 basic medicineCT scanLung NeoplasmsRadioteràpiaMedicine (miscellaneous)030209 endocrinology & metabolismComputed tomographyDigestive System NeoplasmsBody composition03 medical and health sciences0302 clinical medicineHounsfield scalemedicineHumansAgedRetrospective StudiesCancerAged 80 and overThird lumbar vertebraLumbar Vertebrae030109 nutrition & dieteticsNutrition and DieteticsCt planningmedicine.diagnostic_testRadiotherapybusiness.industryRadiotherapy Planning Computer-AssistedCancerMiddle Agedmedicine.diseaseHighly sensitiveBody CompositionFemaleRadiotherapy treatmentSubcutaneous adipose tissueTomography X-Ray ComputedCàncer PacientsNuclear medicinebusiness
researchProduct

A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in pati…

1993

After informed consent, 86 patients with advanced cancer undergoing potentially myelosuppressive cytotoxic chemotherapy were randomized to receive placebo or subcutaneous granulocyte - colony stimulating factor (G- CSF) 5 μg/Kg/day in order to prevent severe neutropenia and its related morbidity. The incidence of neutropenia (absolute neutrophil count <1, 000/mm3) was significantly reduced in patients receiving G-CSF than in controls (18% versus 42%; P <0.05). The duration of neutropenia was also shortened by the administration of G-CSF (4.8 versus 8.2 days; P <0.05). Therapy with G-CSF has also a positive impact on the dose-intensity of employed regimens. Patients treated with G-CSF showed…

AdultMale0301 basic medicineMicrobiology (medical)medicine.medical_specialtyNeutropeniaTime FactorsFeverInjections Subcutaneousmedicine.medical_treatment030106 microbiologyAntineoplastic AgentsNeutropeniaGranulocytePlaceboGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineGranulocyte Colony-Stimulating FactormedicineHumansPharmacology (medical)Prospective StudiesNeoplasm MetastasisAgedPharmacologyChemotherapybusiness.industryIncidenceIncidence (epidemiology)CarcinomaMiddle Agedmedicine.diseaseRecombinant ProteinsGranulocyte colony-stimulating factorSurgeryInfectious DiseasesGranulocyte macrophage colony-stimulating factormedicine.anatomical_structureOncology030220 oncology & carcinogenesisAbsolute neutrophil countFemalebusinessmedicine.drug
researchProduct

Contact dermatitis due to nickel allergy in patients suffering from non-celiac wheat sensitivity

2017

Background: Non‐celiac wheat sensitivity (NCWS) is a new clinical entity in the world of gluten‐related diseases. Nickel, the most frequent cause of contact allergy, can be found in wheat and results in systemic nickel allergy syndrome and mimics irritable bowel syndrome (IBS). Objective: To evaluate the frequency of contact dermatitis due to nickel allergy in NCWS patients diagnosed by a double‐blind placebo‐controlled(DBPC)challenge,and to identify the characteristics of NCWS patients with nickel allergy. Methods: We performed a prospective study of 60 patients (54 females, 6 males; mean age 34.1 ± 8.1 years) diagnosed with NCWS from December 2014 to November 2016; 80 age‐ and sex‐matched…

AdultMale0301 basic medicineNickel allergymedicine.medical_specialtyLetterSettore MED/09 - Medicina InternaNon-celiac wheat sensitivitynon-celiac wheat insensitivityNickel allergyWheat HypersensitivityArticlecutaneous symptoms03 medical and health sciences0302 clinical medicineDouble-Blind MethodNickelHypersensitivitymedicineCutaneous symptomHumansIngestionIn patientProspective StudiesProspective cohort studysystemic nickel allergy syndromeTriticumIrritable bowel syndromeNutrition and Dieteticsbusiness.industryCase-control studyPatch testnon‐celiac  wheat  sensitivity;  nickel  allergy;  cutaneous  symptoms;  irritable  bowel  syndromeCutaneous symptoms; Irritable bowel syndrome; Nickel allergy; Non-celiac wheat sensitivity; Food SciencePatch Testsmedicine.diseaseintradermal testingDermatologySurgeryIrritable bowel syndromenickel allergy ; non-celiac wheat sensitivity ; irritable bowel syndrome ; cutaneous symptoms030104 developmental biologyCase-Control StudiesDermatitis Allergic ContactFemale030211 gastroenterology & hepatologybusinessContact dermatitisFood Science
researchProduct

Clinicopathological study of oral focal mucinosis : a retrospective case series

2018

Background Oral focal mucinosis (OFM) is a rare soft tissue lesion of unknown etiology that exhibits tumor-like growth. It is considered the oral counterpart of cutaneous focal mucinosis or cutaneous myxoid cyst. This is a retrospective study of oral OFM diagnosed over a period of 42 years at an oral pathology service. Material and Methods Clinical, histopathological and immunohistochemical data were analyzed. Alcian blue staining and S-100 immunohistochemistry were performed. Results Eleven cases were retrieved (4:1 female-to-male ratio). The mean age was 44 years. The gingiva was the most affected site. The main clinical presentation was sessile or pedunculated lesions of fibrous or hyper…

AdultMale0301 basic medicinePathologymedicine.medical_specialtyMucinosesAsymptomatic03 medical and health sciences0302 clinical medicineOral and maxillofacial pathologymedicineHumansGeneral DentistryAgedRetrospective StudiesOral Medicine and Pathologybusiness.industryResearchDiagnosis OralMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseStaining030104 developmental biologyOtorhinolaryngologyCutaneous focal mucinosisUNESCO::CIENCIAS MÉDICAS030221 ophthalmology & optometryEtiologyImmunohistochemistryFemaleSurgerymedicine.symptomDifferential diagnosisMouth DiseasesMyxoid cystbusiness
researchProduct

Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.

2017

The treatment of neuropathic pain due to low-back (lumbosacral) radiculopathies, a common source of neuropathic pain, is challenging and often requires a multimodal therapeutic approach. The capsaicin 8% patch is the first topical analgesic licensed for peripheral neuropathic pain. To evaluate this treatment, a subset of patients with painful radiculopathy (lumbar and cervical, including ventral and dorsal rami) enrolled into the multicenter, non-interventional QUEPP study (QutenzaOf the 1044 study participants, 50 were diagnosed with painful radiculopathy as only peripheral neuropathic pain syndrome and were eligible for evaluation. Patients received a single treatment (visit 1) with follo…

AdultMaleAdministration Cutaneous03 medical and health sciences0302 clinical medicineLumbarQuality of life030202 anesthesiologySurveys and QuestionnairesMedicineHumansRadiculopathyAgedReferred painbusiness.industryPruritusGeneral MedicineMiddle Agedmedicine.diseaseLow back painSpineTreatment OutcomeAnesthesiaNeuropathic painNeuralgiaQuality of LifeNeuralgiaFemalemedicine.symptomCapsaicinbusinessRadiculopathies030217 neurology & neurosurgeryLumbosacral jointCurrent medical research and opinion
researchProduct

Unusual clinical variants of cutaneous leishmaniasis in Sicily

2009

Background  The term “leishmaniasis” defines a group of vector-borne diseases caused by species of the genus Leishmania and characterized by a spectrum of clinical manifestations. Parasite properties (infectivity, pathogenicity, virulence), host factors, and host responses regulate heterogeneous disease expression. Sicily is one of the major islands of the Mediterranean Basin and is considered to be a hypo-endemic area for cutaneous leishmaniasis. Leishmania infantum is the most common species on the island. Methods  Fifty patients (both sexes and different ages) with lesions clinically suggestive of cutaneous leishmaniasis were recorded over a 1-year period. The diagnosis was based on posi…

AdultMaleAdolescentErysipeloidLeishmaniasis CutaneousVirulenceDermatologylaw.inventioncutaneous leishmaniasisYoung AdultCutaneous leishmaniasislawSettore MED/35 - Malattie Cutanee E VenereeAnimalsHumansMedicineLeishmania infantumChildSicilyPolymerase chain reactionAgedSkinAged 80 and overInfectivitybiologybusiness.industryInfantLeishmaniasisMiddle Agedmedicine.diseasebiology.organism_classificationLeishmaniaChild PreschoolImmunologyFemaleLeishmania infantumbusinessInternational Journal of Dermatology
researchProduct

Gonadotropin Secretion in Eugonadotropic Human Males and Postmenopausal Females Under Long Term Application of a Potent Analog of Gonadotropin-Releas…

1978

Long-acting analogs are of special interest in long-term treatment with gonadotropin-releasing hormone (GnRH). However, inhibitory effects of agonist analogs on gonadotropin secretion or on reproductive processes have been observed in rats as well as in human males. Since these inhibitory effects seem to be dose-related, we checked the findings for d-Leu 6 -des-Gly 10 -GnRH-ethylamide within the dose range proposed by us for treatment. In six eugonadotropic human males, a significant decrease of luteinizing hormone and follicle-stimulating hormone responsiveness to a standard dose of GnRH and significant decrease of testosterone basal secretion were observed after 2 and 4weeks of subcutaneo…

AdultMaleAgonistendocrine systemmedicine.medical_specialtyTime Factorsmedicine.drug_classInjections SubcutaneousGonadotropin-releasing hormoneHuman MalesBiologyGonadotropin-Releasing HormoneBasal (phylogenetics)Internal medicinemedicineHumansTestosteroneAdministration IntranasalTestosteroneObstetrics and GynecologyLuteinizing HormoneGonadotropin secretionEndocrinologyReproductive MedicineFemaleFollicle Stimulating HormoneMenopauseLuteinizing hormonePituitary Hormone-Releasing Hormoneshormones hormone substitutes and hormone antagonistsHormoneFertility and Sterility
researchProduct

Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy

2020

In Oceania, North America and north-western Europe, after decades of increase, cutaneous malignant melanoma (CMM) rates began to stabilise or decline before 2000. Anecdotal evidence suggests that the reversal of the incidence trend is extending to southern Europe. To obtain a formal confirmation, this nationwide study from Italy investigated the incidence trends by birth cohort. Twenty-one local cancer registries covering a population of 15 814 455 provided incidence data for primary CMM registered between 1994 and 2013. Trends in age-standardised rates were analysed using joinpoint regression models and age-period-cohort models. Age-standardised incidence showed a consistent increase throu…

AdultMaleCancer ResearchSkin NeoplasmsAdolescentAge-period-cohort modelling birth cohort cutaneous malignant melanoma incidence time trendPopulationSocio-culturaleRate ratioSettore MED/42 - Igiene Generale E ApplicataRisk AssessmentYoung Adult03 medical and health sciences0302 clinical medicineage-period-cohort modellingHumansMedicineRegistrieseducationMelanomaAgedAged 80 and overeducation.field_of_studyGeographybusiness.industryIncidence (epidemiology)Melanomabirth cohortMiddle Agedmedicine.diseaseConfidence intervalAnnual Percent Changetime trendItalyOncology030220 oncology & carcinogenesisCohortincidenceFemalebusinessBirth cohortcutaneous malignant melanomaDemography
researchProduct